Royal Bank of Canada Lowers Zimmer Biomet (NYSE:ZBH) Price Target to $112.00
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price objective lowered by investment analysts at Royal Bank of Canada from $125.00 to $112.00 in a research report issued to clients and investors on Tuesday, MarketBeat reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. Royal Bank of Canada’s price […]
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price objective lowered by investment analysts at Royal Bank of Canada from $125.00 to $112.00 in a research report issued to clients and investors on Tuesday, MarketBeat reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. Royal Bank of Canada’s price […]
